Bayforest Capital LTD Acadia Pharmaceuticals Inc Transaction History
Bayforest Capital LTD
- $229 Billion
- Q2 2025
A detailed history of Bayforest Capital LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Bayforest Capital LTD holds 3,224 shares of ACAD stock, worth $66,478. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,224
Previous 13,029
75.26%
Holding current value
$66,478
Previous $216 Million
67.87%
% of portfolio
0.03%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding ACAD
# of Institutions
347Shares Held
163MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$885 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$315 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$249 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$185 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$127 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.34B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...